共 50 条
- [31] Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancerNPJ BREAST CANCER, 2024, 10 (01)Hurvitz, Sara A.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USABardia, Aditya论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Canc Ctr, Boston, MA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USAPunie, Kevin论文数: 0 引用数: 0 h-index: 0机构: Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium Univ Hosp Leuven, Leuven, Belgium Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USA论文数: 引用数: h-index:机构:Carey, Lisa A.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USARugo, Hope S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USADieras, Veronique论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Rennes, France Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USAPhan, See论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci Inc, Foster City, CA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USADelaney, Rosemary论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci Inc, Foster City, CA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USAZhu, Yanni论文数: 0 引用数: 0 h-index: 0机构: Gilead Sci Inc, Foster City, CA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USATolaney, Sara M.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA Fred Hutchinson Canc Ctr, Dept Med, Clin Res Div, UW Med, Seattle, WA 98109 USA
- [33] Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in ChinaINTERNATIONAL JOURNAL OF CANCER, 2020, 147 (12) : 3490 - 3499Chen, Yimeng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaGuan, Yin论文数: 0 引用数: 0 h-index: 0机构: Beijing Chao Yang Hosp, Dept Med Oncol, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaWang, Jiayu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaMa, Fei论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLuo, Yang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaChen, Shanshan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhang, Pin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLi, Qing论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaCai, Ruigang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Beijing Sanhuan Canc Hosp, Dept Med Oncol, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLi, Qiao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaMo, Hongnan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLan, Bo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaChen, Xuelian论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhao, Weihong论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing 100853, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaXu, Binghe论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaFan, Ying论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
- [34] Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerCANCER RESEARCH, 2021, 81 (04)Hurvitz, Sara A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USATolaney, Sara M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAPunie, Kevin论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Leuven, Belgium Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USALoirat, Delphine论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Paris, France Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAOliveira, Mafalda论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Vall dHebron, Barcelona, Spain Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAKalinsky, Kevin论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Med Ctr, New York, NY USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAZelnak, Amelia论文数: 0 引用数: 0 h-index: 0机构: Northside Hosp, Atlanta, GA USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAAftimos, Philippe论文数: 0 引用数: 0 h-index: 0机构: Inst Jules Bordet, Brussels, Belgium Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USADalenc, Florence论文数: 0 引用数: 0 h-index: 0机构: Inst Claudius Regaud, Toulouse, France Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USASardesai, Sagar论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAHamiltion, Erika论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USASharma, Priyanka论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Ctr Canc, Richard & Annette Bloch Canc Care Pavil, Kansas City, KS USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USARecalde, Sabela论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol Hosp, Barcelona, Spain Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAGil, Eva Ciruelos论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Madrid, Spain Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USATraina, Tiffany论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAO'Shaughnessy, Joyce论文数: 0 引用数: 0 h-index: 0机构: Baylor Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USACortes, Javier论文数: 0 引用数: 0 h-index: 0机构: Quiron Grp, IOB Inst Oncol, Madrid, Spain Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USATsai, Michaela论文数: 0 引用数: 0 h-index: 0机构: VPCI Oncol Res, Minneapolis, MN USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAVahdat, Linda论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USADieras, Veronique论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Rennes, France Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USACarey, Lisa论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Ctr Comprehens Canc, Chapel Hill, NC 27515 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USARugo, Hope S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAGoldenberg, David M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAHong, Quan论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAOlivo, Martin论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USAItri, Loretta M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USABardia, Aditya论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
- [35] Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerANNALS OF ONCOLOGY, 2021, 32 (09) : 1148 - 1156Bardia, A.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USATolaney, S. M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAPunie, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Dept Gen Med Oncol, Leuven Canc Inst, Leuven, Belgium Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven Canc Inst, Leuven, Belgium Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USALoirat, D.论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Med Oncol Dept, Paris, France Inst Curie, D3i, Paris, France Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAOliveira, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Vall dHebron, Barcelona, Spain Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Zelnak, A.论文数: 0 引用数: 0 h-index: 0机构: Northside Hosp, Atlanta, GA USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAAftimos, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USADalenc, F.论文数: 0 引用数: 0 h-index: 0机构: Inst Claudius Regaud, Toulouse, France Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USASardesai, S.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, Columbus, OH USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAHamilton, E.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Recalde, S.论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol Hosp, Barcelona, Spain Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAGil, E. C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Madrid, Spain Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USATraina, T.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAO'Shaughnessy, J.论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Med Ctr, Texas Oncol, US Oncol, Dallas, TX USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USACortes, J.论文数: 0 引用数: 0 h-index: 0机构: Int Breast Canc Ctr IBCC, Quiron Grp, Madrid, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Barcelona, Spain Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USATsai, M.论文数: 0 引用数: 0 h-index: 0机构: VPCI Oncol Res, Minneapolis, MN USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAVahdat, L.论文数: 0 引用数: 0 h-index: 0机构: MSK Norwalk Hosp Partnership, Norwalk, CT USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USADieras, V论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Rennes, France Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USACarey, L. A.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USARugo, H. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Comprehens Canc Ctr, San Francisco, CA USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAGoldenberg, D. M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Ctr Mol Med & Immunol, Mendham, NJ USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAHong, Q.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Gilead Sci Inc, Dept Clin Dev, Morris Plains, NJ USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAOlivo, M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Gilead Sci Inc, Dept Clin Dev, Morris Plains, NJ USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAItri, L. M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Gilead Sci Inc, Dept Clin Dev, Morris Plains, NJ USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAHurvitz, S. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, Los Angeles, CA 90095 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
- [36] Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastasesNPJ BREAST CANCER, 2025, 11 (01)Grinda, Thomas论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Gustave Roussy, Dept Med, Villejuif, France Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAMorganti, Stefania论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAHsu, Liangge论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAYoo, Tae-Kyung论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Univ Ulsan, Coll Med, Dept Surg, Div Breast Surg,Asan Med Ctr, Seoul, South Korea Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAKusmick, Ross J.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAAizer, Ayal A.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA论文数: 引用数: h-index:机构:Leone, Jose P.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USAHughes, Melissa论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USATolaney, Sara M.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USALin, Nancy U.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USASammons, Sarah L.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA 02215 USA
- [37] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancerFUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942Skinner, Karen E.论文数: 0 引用数: 0 h-index: 0机构: Vector Oncol, 6555 Quince,Suite 400, Memphis, TN 38119 USA Vector Oncol, 6555 Quince,Suite 400, Memphis, TN 38119 USAHaiderali, Amin论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, 351 N Sumneytown Pike, North Wales, PA 19454 USA Vector Oncol, 6555 Quince,Suite 400, Memphis, TN 38119 USAHuang, Min论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, 351 N Sumneytown Pike, North Wales, PA 19454 USA Vector Oncol, 6555 Quince,Suite 400, Memphis, TN 38119 USASchwartzberg, Lee S.论文数: 0 引用数: 0 h-index: 0机构: West Canc Ctr, 7945 Wolf River Blvd, Germantown, TN 38138 USA Vector Oncol, 6555 Quince,Suite 400, Memphis, TN 38119 USA
- [38] FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast CancerCLINICAL CANCER RESEARCH, 2021, 27 (07) : 1850 - 1854Wahby, Sakar论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAFashoyin-Aje, Lola论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAOsgood, Christy L.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USACheng, Joyce论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAFiero, Mallorie H.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAZhang, Lijun论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USATang, Shenghui论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAHamed, Salaheldin S.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USASong, Pengfei论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USACharlab, Rosane论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USADorff, Sarah E.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USARicks, Tiffany K.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USABarnett-Ringgold, Kimberly论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USADinin, Jeannette论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAGoldberg, Kirsten B.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Oncol Ctr Excellence, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USATheoret, Marc R.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Oncol Ctr Excellence, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAPazdur, Richard论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Oncol Ctr Excellence, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USAAmiri-Kordestani, Laleh论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USABeaver, Julia A.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
- [39] Sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatmentsANNALS OF ONCOLOGY, 2022, 33 (07) : S650 - S650Xu, B.论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaMa, F.论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaWang, S.论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Canc Ctr, Oncol Dept, Guangzhou, Guangdong, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaTong, Z.论文数: 0 引用数: 0 h-index: 0机构: TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaLi, W.论文数: 0 引用数: 0 h-index: 0机构: First Hosp Jilin Univ, Oncol Dept, Changchun, Jilin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaWu, X.论文数: 0 引用数: 0 h-index: 0机构: Hubei Canc Hosp, Oncol Dept, Wuhan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaWang, X.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Canc Res Inst, Oncol Dept, Hangzhou, Peoples R China Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Oncol, Sch Med, Hangzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaSun, T.论文数: 0 引用数: 0 h-index: 0机构: Liaoning Canc Hosp Inst, Dept Oncol, Shenyang, Liaoning, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaPan, Y.论文数: 0 引用数: 0 h-index: 0机构: Anhui Prov Hosp, Oncol Dept, Hefei, Anhui, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaYao, H.论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaWang, X.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Canc Res Inst, Oncol Dept, Hangzhou, Peoples R China Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Oncol, Sch Med, Hangzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaLuo, T.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, West China Sch Med, Head & Neck Oncol Dept, Chengdu, Sichuan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaYang, J.论文数: 0 引用数: 0 h-index: 0机构: Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Oncol Dept, Xian, Shaanxi, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaZeng, X.论文数: 0 引用数: 0 h-index: 0机构: Chongqing Canc Hosp, Oncol Dept, Chongqing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaZhao, W.论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, 301 Mil Hosp, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaCong, X. J.论文数: 0 引用数: 0 h-index: 0机构: Everest Med, Biometr Dept, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R ChinaChen, J.论文数: 0 引用数: 0 h-index: 0机构: Everest Med, Med, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Oncol Dept, Beijing, Peoples R China
- [40] Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast CancerANNALS OF PHARMACOTHERAPY, 2021, 55 (07) : 921 - 931Seligson, John M.论文数: 0 引用数: 0 h-index: 0机构: Nova Southeastern Univ, Clearwater, FL USA Nova Southeastern Univ, Clearwater, FL USAPatron, Alexandra M.论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Jacksonville, FL 32209 USA Nova Southeastern Univ, Clearwater, FL USABerger, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Nova Southeastern Univ, Clearwater, FL USAHarvey, R. Donald论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Sch Med, Atlanta, GA USA Nova Southeastern Univ, Clearwater, FL USASeligson, Nathan D.论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Jacksonville, FL 32209 USA Nemours Childrens Specialty Care, Jacksonville, FL USA Nova Southeastern Univ, Clearwater, FL USA